New mpox vaccine tested on children in High-Risk region
NCT ID NCT07253675
Summary
This study is testing a new mpox vaccine to see if it is safe and if it creates a strong immune response in the body. It will involve 180 healthy children and adults in the Democratic Republic of the Congo who have never had mpox or a related vaccine. The trial will carefully monitor side effects and measure antibody levels in participants' blood.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MONKEYPOX (MPOX) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.